Urso 250



Indications and Reactions:

Role Indications Reactions
Primary
Biliary Cirrhosis Primary 13.3%
Hepatic Function Abnormal 12.6%
Liver Disorder 8.9%
Pyrexia 7.4%
Hepatitis C 6.7%
Cholelithiasis 5.9%
Hypertension 5.9%
Hepatic Cirrhosis 4.4%
Concomitant Disease Aggravated 3.7%
Drug Use For Unknown Indication 3.7%
Alcoholic Liver Disease 3.0%
Constipation 3.0%
Hepatitis 3.0%
Hyperlipidaemia 3.0%
Nasopharyngitis 3.0%
Renal Failure 3.0%
Rheumatoid Arthritis 3.0%
Asthma 2.2%
Autoimmune Hepatitis 2.2%
Chronic Hepatitis 2.2%
Interstitial Lung Disease 13.7%
Hepatic Function Abnormal 9.6%
Liver Disorder 8.2%
Pyrexia 8.2%
Pneumonia 6.8%
Hepatic Neoplasm Malignant 5.5%
Autoimmune Hepatitis 4.1%
Malaise 4.1%
Off Label Use 4.1%
Pleural Effusion 4.1%
Thrombocytopenia 4.1%
Toxic Skin Eruption 4.1%
Vasculitis 4.1%
Cerebral Infarction 2.7%
Lymphocyte Stimulation Test Positive 2.7%
Melaena 2.7%
Nasopharyngitis 2.7%
Portal Vein Thrombosis 2.7%
Stevens-johnson Syndrome 2.7%
Vasculitis Necrotising 2.7%
Secondary
Drug Use For Unknown Indication 15.6%
Hypertension 10.9%
Product Used For Unknown Indication 9.3%
Renal Transplant 9.3%
Asthma 6.1%
Schizophrenia 5.9%
Cerebral Infarction 5.5%
Gastritis 4.6%
Hepatitis C 3.2%
Hyperlipidaemia 3.2%
Infection 3.2%
Insomnia 2.9%
Back Pain 2.7%
Antitussive Therapy 2.5%
Cardiac Failure Chronic 2.5%
Cholelithiasis 2.5%
Diuretic Therapy 2.5%
Lumbar Spinal Stenosis 2.5%
Prophylaxis 2.5%
Rhinitis Allergic 2.5%
Tracheobronchitis 12.5%
Tubulointerstitial Nephritis 9.7%
Toxic Epidermal Necrolysis 6.9%
Generalised Oedema 5.6%
Hepatic Function Abnormal 5.6%
Interstitial Lung Disease 5.6%
Liver Disorder 5.6%
Pneumonia 5.6%
Pyrexia 5.6%
Sudden Cardiac Death 5.6%
Anaphylactic Shock 4.2%
Upper Respiratory Tract Inflammation 4.2%
White Blood Cell Count Increased 4.2%
Aphasia 2.8%
Cholecystitis Acute 2.8%
Erythema 2.8%
Hyperthermia 2.8%
Hypoglycaemic Encephalopathy 2.8%
Incontinence 2.8%
Physical Assault 2.8%
Concomitant
Hepatitis C 17.5%
Prophylaxis 16.0%
Hypertension 10.6%
Hepatic Neoplasm Malignant 7.3%
Drug Use For Unknown Indication 6.6%
Product Used For Unknown Indication 6.1%
Rheumatoid Arthritis 3.9%
Hepatic Cirrhosis 3.7%
Insomnia 3.6%
Gastritis 3.0%
Constipation 2.8%
Diabetes Mellitus 2.5%
Stem Cell Transplant 2.5%
Immunosuppression 2.4%
Infection Prophylaxis 2.2%
Hepatic Function Abnormal 2.0%
Hiv Infection 1.9%
Liver Disorder 1.8%
Gastritis Prophylaxis 1.8%
Pyrexia 1.7%
White Blood Cell Count Decreased 11.4%
Pyrexia 8.8%
Renal Impairment 8.3%
Rash 6.9%
Platelet Count Decreased 6.5%
Hepatic Function Abnormal 6.4%
Palmar-plantar Erythrodysaesthesia Syndrome 6.3%
Vomiting 4.8%
Liver Disorder 4.7%
Sepsis 4.6%
Interstitial Lung Disease 4.5%
Anaemia 4.0%
Pneumonia 3.4%
Hepatic Neoplasm Malignant 2.9%
Decreased Appetite 2.9%
Renal Failure Acute 2.8%
White Blood Cell Count Increased 2.8%
Thrombocytopenia 2.7%
Stomatitis 2.7%
Hepatic Failure 2.5%